SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1074248409333490v1
14/2/89    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tang, D. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, D. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

p130 Crk-Associated Substrate (CAS) in Vascular Smooth Muscle

Dale D. Tang, MD, PhD

Center for Cardiovascular Sciences, Albany Medical College, Albany, New York, tangd{at}mail.amc.edu

Vascular smooth muscle is a key effector in the wall of blood vessels during the pathogenesis of hypertension. Various factors directly elicit smooth muscle cell contraction, migration, growth, and hypertrophy, which lead to the progression of hypertension. Crk-associated substrate (CAS), the first discovered member of the adapter protein CAS family, has recently emerged as a critical cellular component that regulates smooth muscle functions. In this review, the molecular structure and protein interactions of the CAS family members are summarized. Evidence for the role of CAS in the regulation of vascular smooth muscle contractility, cell migration, hypertrophy, and growth is presented. Regulation of CAS by novel tyrosine kinases/phosphatases and unique downstream signaling partners of CAS are also discussed. These new findings establish the important role for CAS in regulating vascular smooth muscle functions. The CAS-associated processes may be new biological targets for the development of new treatment of cardiovascular diseases such as hypertension.

Key Words: Crk-associated substrate protein • cytoskeleton • muscle contraction • cell movement • cardiovascular diseases

This version was published on June 1, 2009

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 14, No. 2, 89-98 (2009)
DOI: 10.1177/1074248409333490


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Chen, R. Wang, Q.-F. Li, and D. D. Tang
Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H533 - H539.
[Abstract] [Full Text] [PDF]



Advertisement